Navigation Links
NHGRI expands effort to revolutionize sequencing technologies

"Modulating Nucleotide Size in DNA for Detection by Nanopore"

This group will design and synthesize modified nucleotides of different sizes, which can be incorporated into DNA. When passed through nanopores, the differences between these modified nucleotides will be easier to detect, producing clean sequencing data.

Bhubaneswar (Bud) Mishra, Ph.D., New York University, New York.
$585,000 (2 years)
"Haplotype Sequencing Via Single Molecule Hybridization"

Investigators from this group will hybridize short DNA probes to genomic DNA fragments to determine sequence information. In addition, they will use optical mapping to create restriction maps to help assemble the genome once it is sequenced. The group will then demonstrate how to combine the sequence and maps into distinct haplotype sequences.

Gregory L. Timp, Ph.D., University of Illinois at Urbana-Champaign.
$2.1 million (3 years)
"Sequencing a DNA Molecule Using a Synthetic Nanopore"

This group will explore the feasibility of sequencing a DNA molecule using a type of silicon integrated circuit. The circuit incorporates a nanopore mechanism with a molecular trap that forces the DNA molecule to oscillate back and forth between electrodes, measuring the electrical signal associated with each specific base.

Stephen W. Turner, Ph.D., Nanofluidics, Menlo Park, Calif.
$6.6 million (3 years)
"Real-Time Multiplex Single-Molecule DNA Sequencing"

This group will leverage their "zero-mode waveguide" technology to detect single nucleotides in real-time, as they are incorporated by a DNA polymerase into a growing DNA molecule. The ultimate goal is to create a real-time, multiplex single-molecule DNA sequencing system that produces sequence reads containing hundreds of thousands of nucleotides.

"$100,000 Genome" Grants

NHGRI's "Near-Term Development for Genome Sequencing" grants will support research aimed at sequencing a
'"/>

Source:NIH


Page: 1 2 3 4 5

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI announces new sequencing targets
4. NHGRI announces latest sequencing targets
5. NHGRI aims to make DNA sequencing faster, more cost effective
6. International HapMap consortium expands mapping effort
7. Gene expands malarias invasion options
8. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
9. New book expands biological classifications to account for alien life
10. New study expands understanding of the role of RNA editing in gene control
11. NIAID expands capability for influenza research and surveillance

Post Your Comments:
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
(Date:11/24/2009)...s fish food is a matter of debate. A high-profile ...st 50 percent of their carbon from trees and leave...estrial and aquatic ecosystems. , But new resear... not likely to be true. Algae provide a much riche...to research published this week in the Proceeding...
(Date:11/24/2009)... available in Spanish . , The presence of i...inflammatory substances in the blood, hinders the ... research project of the University of Navarra con... the School of Pharmacy. , The project, entitled...n to the control of body weight and inflammation,"...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 1Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 2Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6
...er development may provide protection against high...ording to researchers at Purdue University and the...scovered the new preventative drug and have tested...nes, the new vaccine could be produced quickly and...emic of dangerous disease-causing avian influenza ...
...or truck trailers by mounting sideskirts can lead ...o as much as 15%. Earlier promising predictions, b...by TU Delft, have been confirmed during road tests...rivate platform PART (Platform for Aerodynamic Roa...n immediately be put into production. , It is exp...
... , , Every two minutes in Germany, one person su... not survive the sudden lack of blood in the brain...Since the brain is a high-performance organ with a...gen is interrupted, it reacts with paralyses, impa...ng of the underlying processes in the brain, resea...
Other Biology News:New vaccine may give long-term defense against deadly bird flu and its variant forms 2New vaccine may give long-term defense against deadly bird flu and its variant forms 3New vaccine may give long-term defense against deadly bird flu and its variant forms 4Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Tracking stroke 2
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
(Date:11/24/2009)...land, November 24 deCODE...at it has received notice from,the Nasdaq Stock Ma...ll be,suspended as of November 30, 2009 and a Form...ange Commission, which will remove deCODE,s common...files an appeal to the Nasdaq,Listing Qualificatio...
(Date:11/24/2009)... NeurogesX, Inc. (Nasdaq:...eveloping and commercializing novel pain managemen... President and Chief Executive Officer, is schedul...lth Care Conference, to be held December 1-2, 2009...k. ,, Mr. DiTonno and Stephen Ghiglieri, Chief...
(Date:11/24/2009)...O, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Thorn..., a leading provider of advanced laser systems and...ity clinic markets, today reported operational and...tember 30, 2009. , , Q3 2009 Highlights, -...illion in Q3 2008, - Gross profit margin was ...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
...attendees from 47 countries convene in Seattle for...ce, SEATTLE, Aug. 20 More than 900 global resear...k for the AIDS Vaccine 2007,Conference at the Sher...ine,2000 Conference in Paris, this event has emerg...ific information relating to the difficult task of...
...ug. 14 Transgenomic, Inc. (the,"Company") (OTC Bu...lts for,the quarter ended June 30, 2007. The Compa... that follow. Second Quarter 2007 The Company re...hare,for the second quarter of 2007 as compared to... the second quarter of 2006. The 2007 net profit w...
...ug. 14 Response Genetics, Inc.,(Nasdaq: RGDX ), ...arter,ended June 30, 2007. "The second quarter of...nning with our successful initial public offering ...EO of Response Genetics. "We are very,pleased by t...ced. During,the quarter these developments include...
Other Biology Technology:Global Experts Explore Entire Spectrum of Aids Vaccine Development 2Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Response Genetics Reports Second Quarter 2007 Financial Results 2Response Genetics Reports Second Quarter 2007 Financial Results 3Response Genetics Reports Second Quarter 2007 Financial Results 4Response Genetics Reports Second Quarter 2007 Financial Results 5Response Genetics Reports Second Quarter 2007 Financial Results 6Response Genetics Reports Second Quarter 2007 Financial Results 7Response Genetics Reports Second Quarter 2007 Financial Results 8
Cyno Serum from Innovative Research
Marmoset serum from Alpha Genesis, Inc.
Anti-Foam Reagent from Promega
EPH electrode, cathode from GE Healthcare, formerly Amersham Biosciences
Biology Products: